Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
Author:
Funder
National Key Research and Development Project of China
Guangdong Natural Science Foundation
Publisher
Elsevier BV
Reference76 articles.
1. Small molecule inhibitors as emerging cancer therapeutics;Lavanya;Integr Cancer Sci Ther,2014
2. Small-molecule kinase inhibitors: an analysis of FDA-approved drugs;Wu;Drug Discov Today,2016
3. Small-molecule PROTACS: new approaches to protein degradation;Toure;Angew Chem Int Ed Engl,2016
4. The dynamic nature of the kinome;Graves;Biochem J,2013
5. Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands;Gechijian;Nat Chem Biol,2018
Cited by 298 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EGFR inhibitors across generations: Progress, challenges, and future directions;Journal of Molecular Structure;2025-09
2. Monoclonal antibody neutralizes Staphylococcus aureus serine protease-like protein B (SplB)-induced pathology;Infection and Immunity;2025-06-13
3. Proteolysis targeting chimeras (PROTACs) in oncology: a review of patents and regulatory considerations;Pharmaceutical Patent Analyst;2025-05-15
4. Post-Translational Modifications in Multiple Myeloma: Mechanisms of Drug Resistance and Therapeutic Opportunities;Biomolecules;2025-05-12
5. Silica-based EGFR-degrading nano-PROTACs for efficient therapy of non-small cell lung cancer;European Journal of Pharmaceutics and Biopharmaceutics;2025-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2025 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3